Perspectives on the PUNCH CD Trial of a Microbiota-Based Drug Targeted at Recurrent C. diff. Infection
Kathy Tracey, LPN, CCRC, Manager of Clinical Research, Chevy Chase Clinical Research, Chevy Chase, MD; Mary Kay Sobcinski, RN, MHA, Rebiotix Inc., Roseville, MN